Editorial
Human enhancement drugs: Emerging issues and responses

https://doi.org/10.1016/j.drugpo.2021.103459Get rights and content

Section snippets

Motivations for use of ‘enhancement drugs’

While the use of drugs for human enhancement is a long-standing phenomenon, it has most commonly been described among those who engage in sporting activities, in particular elite-level sport and bodybuilding (Kanayama & Pope, 2018). However, as this collection illustrates, drugs can be used with the aim of enhancing many aspects of life - appearance, performance and functioning – e.g. building muscle, stimulating creativity, improving cognition and functioning, increasing stamina and

Populations

The use of drugs for muscular enhancement, particularly the use of AAS, is arguably the most studied aspect of human enhancement drug use, in part due to its historical association with doping in sport. AAS use outside of sport has been predominantly studied amongst men. Whilst AAS use appears to be much more common among men than women, AAS are still used by a substantial number of women. Although women's bodies are at a significantly greater risk of harm from AAS use, very little research has

Range of drugs used for enhancement

The range of drugs being used for enhancement is increasing, with new substances often first emerging among groups already using established enhancement drugs. The use of drugs for muscular enhancement has typically centred on the use of AAS and associated drugs, however the use of a range of other substances has also emerged amongst the enhanced bodybuilding population over the last 35 years. McVeigh, Salinas and Ralphs (2021) in their commentary explore the emergence of a number of substances

Closing thoughts

As there can be multiple reasons, for the use of a drug, the ’categorisation’ of the use of that drug can thus be blurred. For example, a type of drug that can be used for ‘enhancement’ may also have therapeutic uses. However, simply pointing out that drugs can have both therapeutic and enhancement uses does not render this distinction meaningless, or imply that these different uses do not warrant different ethical and policy responses. The complexities in the categorisation of the use of

Declarations of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References (37)

Cited by (4)

View full text